Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K PUNT

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the South African Veterinary Association|September 11, 2002
Factors related to high levels of ostrich chick mortality from hatching to 90 days of age in an intensive rearing systemS W Cloete, H Lambrechts, K Punt, et al.
British Journal of Haematology|June 1, 1984
The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapseH C van Prooijen, A W Dekker, K Punt
Cancer|October 15, 1985
Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management, and predictive factorsA W Dekker, A Elderson, K Punt, et al.
Scandinavian Journal of Haematology|January 1, 1986
Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara-C) penetration into the cerebrospinal fluid during high-dose Ara-C therapy?H C van Prooijen, P Muus, J M Roelofs, et al.
Human Genetics|February 23, 1978
Human erythrocyte pyruvate kinase deficiency: the use of a kinetic study of mutant enzymes for the detection of heterozygotesE D Sprengers, J Marie, A Kahn, et al.
British Journal of Haematology|September 1, 1985
Age dependent behaviour of red cell glycolytic enzymes in haematological disordersG Jansen, L Koenderman, G Rijksen, et al.
British Journal of Haematology|October 1, 1984
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromesG Tricot, R De Bock, A W Dekker, et al.
Blood|April 1, 1985
Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancyL F Verdonck, A W Dekker, M L van Kempen, et al.
Science (New York, N.Y.)|October 20, 2000
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationD H Barouch, S Santra, J E Schmitz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the South African Veterinary Association|September 11, 2002
Factors related to high levels of ostrich chick mortality from hatching to 90 days of age in an intensive rearing systemS W Cloete, H Lambrechts, K Punt, et al.
British Journal of Haematology|June 1, 1984
The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapseH C van Prooijen, A W Dekker, K Punt
Cancer|October 15, 1985
Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management, and predictive factorsA W Dekker, A Elderson, K Punt, et al.
Scandinavian Journal of Haematology|January 1, 1986
Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara-C) penetration into the cerebrospinal fluid during high-dose Ara-C therapy?H C van Prooijen, P Muus, J M Roelofs, et al.
Human Genetics|February 23, 1978
Human erythrocyte pyruvate kinase deficiency: the use of a kinetic study of mutant enzymes for the detection of heterozygotesE D Sprengers, J Marie, A Kahn, et al.
British Journal of Haematology|September 1, 1985
Age dependent behaviour of red cell glycolytic enzymes in haematological disordersG Jansen, L Koenderman, G Rijksen, et al.
British Journal of Haematology|October 1, 1984
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromesG Tricot, R De Bock, A W Dekker, et al.
Blood|April 1, 1985
Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancyL F Verdonck, A W Dekker, M L van Kempen, et al.
Science (New York, N.Y.)|October 20, 2000
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationD H Barouch, S Santra, J E Schmitz, et al.
Pageof 1